What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His scientific interests lie mostly in Internal medicine, Fibrosis, Transforming growth factor, Pathology and Endocrinology.
John Varga studies Interstitial lung disease which is a part of Internal medicine.
The study incorporates disciplines such as Cancer research, Scleroderma, Immunology and Connective tissue in addition to Fibrosis.
His studies in Transforming growth factor integrate themes in fields like Fibroblast, Adipogenesis and Phosphorylation.
While the research belongs to areas of Pathology, John Varga spends his time largely on the problem of Lung, intersecting his research to questions surrounding Fibroblast migration, Catenin, Mitochondrion and Mitochondrial ROS.
His Endocrinology research is multidisciplinary, incorporating perspectives in Peroxisome proliferator-activated receptor, Receptor, Autocrine signalling and Cell biology.
His most cited work include:
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association (1995 citations)
- 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative (1669 citations)
- Cyclophosphamide versus placebo in scleroderma lung disease. (1084 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Fibrosis, Internal medicine, Scleroderma, Immunology and Pathology.
John Varga has included themes like Transforming growth factor, Cancer research, Pathogenesis and Fibroblast in his Fibrosis study.
John Varga interconnects Regulation of gene expression and Signal transduction in the investigation of issues within Transforming growth factor.
His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Cardiology.
His work deals with themes such as Autoimmune disease, Clinical trial and Surgery, which intersect with Scleroderma.
His study looks at the relationship between Immunology and topics such as Disease, which overlap with Physical therapy.
He most often published in these fields:
- Fibrosis (33.33%)
- Internal medicine (27.58%)
- Scleroderma (24.22%)
What were the highlights of his more recent work (between 2017-2021)?
- Fibrosis (33.33%)
- Scleroderma (24.22%)
- Immunology (23.02%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Fibrosis, Scleroderma, Immunology, Internal medicine and Pathology.
His Myofibroblast study, which is part of a larger body of work in Fibrosis, is frequently linked to CD38, bridging the gap between disciplines.
His Scleroderma study combines topics in areas such as Cyclophosphamide, Disease, Transplantation and Interstitial lung disease.
His Immunology study combines topics from a wide range of disciplines, such as Blood proteins and Hematopoietic stem cell transplantation.
His Nintedanib study in the realm of Internal medicine interacts with subjects such as DLCO.
His Pathology research is multidisciplinary, incorporating elements of Microbiome, Rodent model, Fasciitis and Gene expression.
Between 2017 and 2021, his most popular works were:
- Emerging targets of disease-modifying therapy for systemic sclerosis. (37 citations)
- Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS). (33 citations)
- TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
His main research concerns Fibrosis, Immunology, Scleroderma, Cancer research and Myofibroblast.
His studies deal with areas such as Pathogenesis, Inflammation, Autoimmune disease, Innate immune system and Gene isoform as well as Fibrosis.
John Varga combines subjects such as Cross-sectional study, Disease progression and Organ involvement with his study of Immunology.
He has researched Scleroderma in several fields, including Autoantibody, Human leukocyte antigen, Antigen and Allele, Allele frequency.
His Myofibroblast research incorporates themes from Pulmonary fibrosis and TLR4.
His Interstitial lung disease study necessitates a more in-depth grasp of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
